Filana Therapeutics, Inc. Net Asset Momentum
Filana Therapeutics, Inc. net asset momentum. Filana Therapeutics, Inc. (FLNA) recorded a net asset momentum of -48.9% as of December 2025, with net assets of $74.40 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore FLNA operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Filana Therapeutics, Inc. (2022–2025)
Net asset momentum of Filana Therapeutics, Inc. from 2022 to 2025. This chart tracks Filana Therapeutics, Inc.'s year-over-year net asset growth across 4 annual reporting periods from 2022 to 2025. The most recent momentum reading is -48.9%, with net assets of $74.40 Million USD as of December 2025. See FLNA net assets for net asset value and shareholders' equity analysis.
Filana Therapeutics, Inc. Net Asset Momentum by Year (2022–2025)
Filana Therapeutics, Inc. net asset momentum by year from 2022 to 2025. The table below shows the complete annual net asset history for Filana Therapeutics, Inc. from 2022 to 2025, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see how much is Filana Therapeutics, Inc. worth.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $74.40 Million | $118.36 Million | $43.95 Million | ▼ -48.9% |
| 2024 | $145.70 Million | $157.53 Million | $11.83 Million | ▲ +6.0% |
| 2023 | $137.47 Million | $151.66 Million | $14.20 Million | ▼ -39.6% |
| 2022 | $227.54 Million | $234.83 Million | $7.29 Million | — |